KELSEY PERKINS: Open Payments
NPI 1275284515 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,865 in 273 payments from 21 companies in 2025. Trend: 2023 $2,081 · 2024 $2,046 · 2025 $3,865
Food & beverage: $3,865
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $744 |
| Janssen Biotech, Inc. | 41 | $640 |
| Phathom Pharmaceuticals, Inc. | 56 | $517 |
| Madrigal Pharmaceuticals | 19 | $463 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 37 | $440 |
| Ardelyx, Inc. | 23 | $247 |
| GENZYME CORPORATION | 7 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $139 |
| QOL Medical, LLC | 7 | $115 |
| Regeneron Healthcare Solutions, Inc. | 5 | $93 |
Products named: TREMFYA, VOQUEZNA, RINVOQ, REZDIFFRA, XIFAXAN, DUPIXENT, IBSRELA, ENTYVIO.
Industry payments across KY — which companies pay providers there.
